Hangzhou Qihan Biotech Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Hangzhou Qihan Biotech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus (NCT07444307) | Hangzhou Qihan Biotech Co., Ltd. | 2025-12-15 |
Track Hangzhou Qihan Biotech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.